Rett syndrome and neuronal development

Journal of Child Neurology

Volumn 20, Issue 9, 2005, Pages 759-763

  Johnston, Michael V ^a,b   Blue, Mary E ^a   Naidu, Sakkubai ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; GLUTAMIC ACID; METHYL CPG BINDING PROTEIN 2; NEUROTRANSMITTER RECEPTOR; TRANSCRIPTION FACTOR DLX5;

ARTICLE; AUTOPSY; BRAIN DEVELOPMENT; CEREBELLUM; GENE CONTROL; GENETIC DISORDER; HUMAN; NERVE GROWTH; NOSE MUCOSA; OLFACTORY RECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETT SYNDROME; SYNAPSE;

EID: 27144523524     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738050200091101     Document Type: Article

References (41)

1. Naidu S: Rett syndrome: A disorder affecting early brain growth. Ann Neurol 1997;42:3-10.
2. Hagberg B: Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev 2002;8:61-65.
3. Armstrong DD: Rett syndrome neuropathology review 2000. Brain Dev 2001;23(Suppl 1):S72-S76.
4. Subramaniam B, Naidu S, Reiss AL: Neuroanatomy in Rett syndrome: Cerebral cortex and posterior fossa. Neurology 1997;48:399-407.
5. Johnston MV, Nishimura A, Harum K, et al: Sculpting the developing brain. Adv Pediatr 2001;48:1-38.
6. Huttenlocher PR: Morphometric study of human cerebral cortex development. Neuropsychologia 1990;28:517-527.
7. Johnston MV, Jeon OH, Pevsner J, et al: Neurobiology of Rett syndrome: A genetic disorder of synapse development. Brain Dev 2001;23(Suppl 1):S206-S213.
8. Belichenko PV, Hagberg B, Dahlstrom A: Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol (Berl) 1997;93:50-61.
9. Kaufmann WE, MacDonald SM, Altamura CR: Dendritic cytoskeletal protein expression in mental retardation: An immunohistochemical study of the neocortex in Rett syndrome. Cereb Cortex 2000;10:992-1004.
10. Blue ME, Naidu S, Johnston MV: Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol 1999;156:345-352.
11. Blue ME, Naidu S, Johnston MV: Development of amino acid receptors in frontal cortex from girls with Rett syndrome. Ann Neurol 1999;45:541-545.
12. Yamashita Y, Matsuishi T, Ishibashi M, et al: Decrease in benzodiazepine receptor binding in the brains of adult patients with Rett syndrome. J Neural Sci 1998;154:146-150.
13. Colantuoni C, Jeon OH, Hyder K, et al: Gene expression profiling in postmortem Rett syndrome brain: Differential gene expression and patient classification. Neurobiol Dis 2001;8:847-865.
14. Shahbazian MD, Antalffy B, Armstrong DL, et al: Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 2002;11:115-124.
15. Jung BP, Jugloff DG, Zhang G, et al: The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J Neurobiol 2003;55:86-96.
16. Mullaney BC, Johnston MV, Blue ME: Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience 2004;123:939-949.
17. Cassel S, Revel MO, Kelche C, et al: Expression of the methyl-CpG-binding protein MeCP2 in rat brain. An ontogenetic study. Neurobiol Dis 2004;15:206-211.
18. Kishi N, Macklis JD: MECP2 is progressively expressed in postmigratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 2004;27:306-321.
19. Aber KM, Nori P, MacDonald SM, et al: Methyl-CpG-binding protein 2 is localized in the postsynaptic compartment: An immunochemical study of subcellular fractions. Neuroscience 2003;116:77-80.
20. Crain B, Cotman C, Taylor D, et al: A quantitative electron microscopic study of synaptogenesis in the dentate gyrus of the rat. Brain Res 1973;63:195-204.
21. Oldfors A, Sourander P, Armstrong DL, et al: Rett syndrome: Cerebellar pathology. Pediatr Neurol 1990;6:310-314.
22. Murakami JW, Courchesne E, Haas RH, et al: Cerebellar and cerebral abnormalities in Rett syndrome: A quantitative MR analysis. AJR Am J Roentgenol 1992;159:177-183.
23. Shahbazian M, Young J, Yuva-Paylor L, et al: Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002;35:243-254.
24. Ronnett GV, Leopold D, Cai X, et al: Olfactory biopsies demonstrate a defect in neuronal development in Rett's syndrome. Ann Neurol 2003;54:206-218.
25. Cohen DR, Matarazzo V, Palmer AM, et al: Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol Cell Neurosci 2003;22:417-429.
26. Matarazzo V, Cohen D, Palmer AM, et al: The transcriptional repressor Mecp2 regulates terminal neuronal differentiation. Mol Cell Neurosci 2004;27:44-58.
27. Chen WG, Chang Q, Lin Y, et al: Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003;302:885-889.
28. Martinowich K, Hattori D, Wu H, et al: DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 2003;302:890-893.
29. Canas N, Pereira IT, Ribeiro JA, et al: Brain-derived neurotrophic factor facilitates glutamate and inhibits GABA release from hippocampal synaptosomes through different mechanisms. Brain Res 2004;1016:72-78.
30. Levine ES, Kolb JE: Brain-derived neurotrophic factor increases activity of NR2B-containing N-methyl-D-aspartate receptors in excised patches from hippocampal neurons. J Neurosci Res 2000;62:357-362.
31. Kovalchuk Y, Hanse E, Kafitz KW, et al: Postsynaptic induction of BDNF-mediated long-term potentiation. Science 2002;295: 1729-1734.
32. Itami C, Kimura F, Kohno T, et al: Brain-derived neurotrophic factor-dependent unmasking of "silent" synapses in the developing mouse barrel cortex. Proc Natl Acad Sci U S A 2003;100: 13069-13074.
33. Kerr AM, Julu PO: Recent insights into hyperventilation from the study of Rett syndrome. Arch Dis Child 1999;80:384-387.
34. Weese-Mayer DE, Bolk S, Silvestri JM, et al: Idiopathic congenital central hypoventilation syndrome: Evaluation of brain-derived neurotrophic factor genomic DNA sequence variation. Am J Med Genet 2002;107:306-310.
35. Balkowiec A, Katz DM: Brain-derived neurotrophic factor is required for normal development of the central respiratory rhythm in mice. J Physiol 1998;510(Pt 2):527-533.
36. Richerson GB, Bekkers JM: Learning to take a deep breath-With BDNF. Nat Med 2004;10:25-26.
37. Baker-Herman TL, Fuller DD, Bavis RW, et al: BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia. Nat Neurosci 2004;7:48-55.
38. Hamberger A, Gillberg C, Palm A, et al: Elevated CSF glutamate in Rett syndrome. Neuropediatrics 1992;23:212-213.
39. Horike S, Cai S, Miyano M, et al: Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 2005;37:31-40.
40. Stuhmer T, Anderson SA, Ekker M, et al: Ectopic expression of the Dlx genes induces glutamic acid decarboxylase and Dlx expression. Development 2002;129:245-252.
41. Panganiban G, Rubenstein JL: Developmental functions of the distal-less/Dlx homeobox genes. Development 2002;129:4371-4386.